Day One Biopharmaceuticals Competitors and Similar CompaniesClear all
Day One Biopharmaceuticals's competitors and similar companies include Bexion Pharmaceuticals, CARsgen Therapeutics, OncoTherapy Science and Calidi Biotherapeutics.
 Day One Biopharmaceuticals Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer. |  Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. |  CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. |  OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. |  Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer. | |
Founding Date | Founding Date 2018 | Founding Date 2006 | Founding Date 2014 | Founding Date 2001 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Covington, US HQ | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US | Locations Kawasaki, JP HQ | Locations San Diego, US HQ Bernried, DE |
Employees | Employees 20 | Employees 274% increase | Employees 100 | Employees 54 | Employees 327% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 56.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $158.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥808.5m (FY, 2026) | Revenue (est.) N/A |
Net income | Net income ($107.3m) (FY, 2025) | Net income N/A | Net income N/A | Net income (¥910.6m) (FY, 2026) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round $ 186m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 8.2m (over 6 years ago) |
Total funding raised | Total funding raised $ 60m | Total funding raised $ 16.6m | Total funding raised $ 276m | Total funding raised N/A | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
Bexion Pharmaceuticals
HQ
Covington, US
Employees
27↑ 4% increase
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
View companyCARsgen Therapeutics
HQ
Shanghai, CN
Employees
100
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
View companyOncoTherapy Science
HQ
Kawasaki, JP
Employees
54
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View companyCalidi Biotherapeutics
HQ
San Diego, US
Employees
32↑ 7% increase
Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
View company